 | • レポートコード：B-MOR-05184 • 出版社/出版日：Mordor Intelligence / 2018年4月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、経腸栄養補給装置の世界市場について調べ、経腸栄養補給装置の世界規模、市場動向、市場環境、製品タイプ別分析、年齢グループ別分析、エンドユーザー別分析、用途別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・経腸栄養補給装置の世界市場インサイト ・経腸栄養補給装置の世界市場環境 ・経腸栄養補給装置の世界市場動向 ・経腸栄養補給装置の世界市場規模 ・経腸栄養補給装置の世界市場規模：製品タイプ別 ・経腸栄養補給装置の世界市場規模：年齢グループ別 ・経腸栄養補給装置の世界市場規模：エンドユーザー別 ・経腸栄養補給装置の世界市場規模：用途別 ・経腸栄養補給装置の世界市場：地域別市場規模・分析 ・経腸栄養補給装置の北米市場規模・予測 ・経腸栄養補給装置のアメリカ市場規模・予測 ・経腸栄養補給装置のヨーロッパ市場規模・予測 ・経腸栄養補給装置のアジア市場規模・予測 ・経腸栄養補給装置の日本市場規模・予測 ・経腸栄養補給装置の中国市場規模・予測 ・経腸栄養補給装置のインド市場規模・予測 ・経腸栄養補給装置の韓国市場規模・予測 ・関連企業情報・競争状況 |
The Enteral Feeding Devices Market is expected to grow at a CAGR of 6.0% during the forecast period. The North America market is expected to account for approximately more than 40% of the market share during the forecast period.
Higher Prevalence of Chronic Diseases
The prevalence of the chronic diseases is rapidly increasing and affecting more than 14 million people around the world. Among all the chronic diseases, cancer is becoming a major concern for the healthcare sector. Diabetes is another major life threatening disease, affecting 400 million people across the globe. Due to these large figures, the demand for enteral feeding devices is increasing.
The other factors driving the enteral feeding devices market are increasing geriatric population, growing adoption of enteral nutrition, particularly in home settings, and higher immature births.
Complications Associated With the Enteral Feeding Tubes
A fraction of the patients with enteral feeding support face many complications, such as maceration, owing to leakage of gastric contents around the feeding tube. The size and rigidity of a nasoenteric feeding tube can result in irritation or inflammation along its path, and at times, can cause gastro-esophageal reflux. The fine bore tubes can sometimes coil-up in the oropharynx or go off course into the trachea, during insertion. This is witnessed more often in unconscious patients. Additional complications due to the usage of artificial nutrition are electrolytic abnormalities, problems with metabolism, among others. All these factors are limiting the practice of using enteral feeding in various areas, globally.
Other factors which are also hindering the growth of the market include, low reimbursements in developing countries, low cost competition from small players, and inadvertent dislodgment of tubes (leading to accidental disabilities and deaths).
North America Dominates the Market
Geographically, North America has accounted for the largest market share of the enteral feeding devices in 2016, followed by Europe. This regional segment shows significant market growth opportunities, owing to high adoption of enteral feeding devices, increasing prevalence of chronic diseases, and presence of many large hospitals. Also, the use of small-bore connectors for connecting the feeding tubes to prevent life-threatening conditions is increasing in the United States, which is also another reason for the growth in enteral feeding devices market in North America.
Key Developments in the Market
• May 2017: Halyard Health adds new drainage system to comprehensive portfolio of enteral feeding products
Major Players: ABBOTT LABORATORIES, B. BRAUN MELSUNGEN AG, BOSTON SCIENTIFIC CORPORATION, C. R. BARD INC., CONMED CORPORATION, COOK MEDICAL INC., FRESENIUS SE & CO. KGAA, HALYARD HEALTH INC., MEDTRONIC PLC, MOOG INC. AND NESTLÉ S.A., amongst others.
Reasons to Purchase this Report
• Current and future global Enteral Feeding Devices Market outlook in the developed and emerging markets
• Various perspectives of the market, with the help of Porter’s five forces analysis
• The segment expected to dominate the market
• The region expected to witness the fastest growth rate during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porters Five Force Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Population of Geriatrics
6.1.2 Higher Immature Births
6.1.3 Growing Adoption of Enteral Nutrition
6.1.4 Higher Prevalence of Chronic Diseases
6.2 Market Restraints
6.2.1 Complications Associated with Enteral Feeding Tubes
6.2.2 Lower Healthcare Reimbursement in Developing Countries
6.2.3 Low Cost Competition from Small Players
6.2.4 Inadvertent Dislodgment of Tubes
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Product Type
7.1.1 Enteral Feeding Pumps
7.1.2 Enteral Feeding Tubes
7.1.2.1 Nasoenteric Feeding Tubes
7.1.2.1.1 Nasogastric Feeding Tubes
7.1.2.1.2 Nasoduodenal Feeding Tubes
7.1.2.1.3 Nasojejunal Feeding Tubes
7.1.2.2 Oroenteric Feeding Tubes
7.1.2.3 Enterostomy Tubes
7.1.2.3.1 Standard Tubes
7.1.2.3.1.1 Gastrostomy Tubes
7.1.2.3.1.2 Jejunostomy Tubes
7.1.2.3.1.3 Gastrojejunostomy Tubes
7.1.2.3.2 Low Profile Tubes
7.1.2.4 Others
7.1.3 Administration Reservoirs
7.1.4 Giving Sets
7.1.5 Enteral Syringes
7.1.6 Others
7.2 By Age Group
7.2.1 Adults
7.2.2 Pediatrics
7.3 By End-user
7.3.1 Hospitals
7.3.2 Ambulatory Care Services
7.3.3 Others
7.4 By Application
7.4.1 Oncology
7.4.2 Gastroenterology
7.4.3 Diabetes
7.4.4 Neurological Disorders
7.4.5 Hypermetabolism
7.4.6 Others
7.5 By Geography
7.5.1 North America
7.5.1.1 United States
7.5.1.2 Canada
7.5.1.3 Mexico
7.5.2 Europe
7.5.2.1 France
7.5.2.2 Germany
7.5.2.3 United Kingdom
7.5.2.4 Italy
7.5.2.5 Spain
7.5.2.6 Rest of Europe
7.5.3 Asia-Pacific
7.5.3.1 China
7.5.3.2 Japan
7.5.3.3 India
7.5.3.4 Australia & New Zealand
7.5.3.5 South Korea
7.5.3.6 Rest of Asia-Pacific
7.5.4 Middle East & Africa
7.5.4.1 GCC
7.5.4.2 South Africa
7.5.4.3 Rest of the Middle East & Africa
7.5.5 South America
7.5.5.1 Brazil
7.5.5.2 Argentina
7.5.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key players
9.1 Abbott Laboratories
9.2 B. Braun Melsungen Ag
9.3 Boston Scientific Corporation
9.4 C. R. Bard Inc.
9.5 Conmed Corporation
9.6 Cook Medical Inc.
9.7 Fresenius Se & Co. Kgaa
9.8 Halyard Health, Inc.
9.9 Medtronic PLC
9.10 Moog Inc.
9.11 Nestle S.A.
9.12 List Not Exhaustive
10. Future of the Market